Home

Kiindulópont Radioaktív kivétel acid alpha glucosidase borda Koksz Társadalom kutatások

Inhibitors of α‐amylase and α‐glucosidase: Potential linkage for whole  cereal foods on prevention of hyperglycemia - Gong - 2020 - Food Science &  Nutrition - Wiley Online Library
Inhibitors of α‐amylase and α‐glucosidase: Potential linkage for whole cereal foods on prevention of hyperglycemia - Gong - 2020 - Food Science & Nutrition - Wiley Online Library

Acid alpha-glucosidase - Wikipedia
Acid alpha-glucosidase - Wikipedia

Detection of Active Mammalian GH31 α-Glucosidases in Health and Disease  Using In-Class, Broad-Spectrum Activity-Based Probes | ACS Central Science
Detection of Active Mammalian GH31 α-Glucosidases in Health and Disease Using In-Class, Broad-Spectrum Activity-Based Probes | ACS Central Science

Pathophysiology of late-onset Pompe disease. Abbreviations: GAA, acid... |  Download Scientific Diagram
Pathophysiology of late-onset Pompe disease. Abbreviations: GAA, acid... | Download Scientific Diagram

Endolysosomal N-glycan processing is critical to attain the most active  form of the enzyme acid alpha-glucosidase - ScienceDirect
Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase - ScienceDirect

Antibodies against recombinant human alpha-glucosidase do not seem to  affect clinical outcome in childhood onset Pompe disease | Orphanet Journal  of Rare Diseases | Full Text
Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease | Orphanet Journal of Rare Diseases | Full Text

Acid alpha-glucosidase or acid maltase, is an enzyme that helps to break  down glycogen in the lysosome. 3d illustration Stock Photo - Alamy
Acid alpha-glucosidase or acid maltase, is an enzyme that helps to break down glycogen in the lysosome. 3d illustration Stock Photo - Alamy

The Pharmacological Chaperone AT2220 Increases the Specific Activity and  Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen  Reduction in a Transgenic Mouse Model of Pompe Disease | PLOS ONE
The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease | PLOS ONE

Consensus treatment recommendations for lateonset Pompe disease
Consensus treatment recommendations for lateonset Pompe disease

Acid alpha-glucosidase or acid maltase, is an enzyme that helps to break  down glycogen in the lysosome. 3d illustration Stock Photo - Alamy
Acid alpha-glucosidase or acid maltase, is an enzyme that helps to break down glycogen in the lysosome. 3d illustration Stock Photo - Alamy

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of  Secretable Acid α-Glucosidase - ScienceDirect
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect

Acid Alpha-glucosidase Molecular Structure Isolated on Black Stock  Illustration - Illustration of hydrogen, oxygen: 177440257
Acid Alpha-glucosidase Molecular Structure Isolated on Black Stock Illustration - Illustration of hydrogen, oxygen: 177440257

Structure of human lysosomal acid α-glucosidase–a guide for the treatment  of Pompe disease | Nature Communications
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease | Nature Communications

Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: a  systemic review | Nutrition & Diabetes
Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: a systemic review | Nutrition & Diabetes

Mechanism of action of alpha-glucosidase inhibitors. | Download Scientific  Diagram
Mechanism of action of alpha-glucosidase inhibitors. | Download Scientific Diagram

PDB-101: Global Health: Diabetes Mellitus: Drugs: Alpha glucosidase  inhibitors: Alpha glucosidase
PDB-101: Global Health: Diabetes Mellitus: Drugs: Alpha glucosidase inhibitors: Alpha glucosidase

Figure 2, Hydrolytic reactions of the red and blue dyes - Probe Reports  from the NIH Molecular Libraries Program - NCBI Bookshelf
Figure 2, Hydrolytic reactions of the red and blue dyes - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf

Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the  Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe  Disease: Molecular Therapy
Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease: Molecular Therapy

PDB-101: Global Health: Diabetes Mellitus: Drugs: Alpha glucosidase  inhibitors: Alpha glucosidase
PDB-101: Global Health: Diabetes Mellitus: Drugs: Alpha glucosidase inhibitors: Alpha glucosidase

ACID ALPHA-GLUCOSIDASE S AND IS MIX - Cambridge Isotope Laboratories -  NSK-PO-1
ACID ALPHA-GLUCOSIDASE S AND IS MIX - Cambridge Isotope Laboratories - NSK-PO-1

PDF) Structure of human lysosomal acid α-glucosidase-A guide for the  treatment of Pompe disease
PDF) Structure of human lysosomal acid α-glucosidase-A guide for the treatment of Pompe disease

α-Glucosidase Inhibitory Activity Assay Kit | [Analytical  Chemistry]Products | Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A.  Corporation
α-Glucosidase Inhibitory Activity Assay Kit | [Analytical Chemistry]Products | Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation

Schematic drawing of consequences of α-glucosidase deficiency and ERT... |  Download Scientific Diagram
Schematic drawing of consequences of α-glucosidase deficiency and ERT... | Download Scientific Diagram

Pompe's Disease and the Effects of Alpha-Glucosidase Deficiency
Pompe's Disease and the Effects of Alpha-Glucosidase Deficiency

Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in  a novel mouse model with early-onset spinal cord and respiratory defects -  eBioMedicine
Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects - eBioMedicine